Back to company

2A Pharma ApS: Financial statements 2020

CVR: 39391597

2A Pharma ApS (CVR 39391597) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,096,492 and a net result of DKK 322,401 compared with DKK -81,364 the year before. That is an increase of 37.4% compared with the year before. Equity amounted to DKK 666,777. The solvency ratio was 63.2%. The company had 3 employees in the financial year.

Gross Profit
2,096,492 kr.
Profit/Loss
322,401 kr.
Equity
666,777 kr.
Total Assets
1,055,388 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-2.1 mio.322 t.667 t.3
2019-1.5 mio.-81 t.344 t.1
2018-947 t.-60 t.426 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is 2A Pharma ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

2A Pharma ApS: The 2019 annual report is outJun 9, 2020

2A Pharma ApS has published its annual report for 2019. Gross profit came to DKK 1,525,401, and the net result was DKK -81,364.

About 2A Pharma ApS

2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees. In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity amounted to DKK 263,490.

Other financial years